Longevity Health Holdings, Inc.
XAGEOTCCIK 1842939Consumer staplesFiscal year ends Dec 31
Reports and events: 99 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-029755 |
| 2026-09-0417:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-029714 |
| 2026-08-1709:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-028120 |
| 2026-08-1417:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-028043 |
| 2026-08-1416:11 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-028011 |
| 2026-06-0416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-257520 |
| 2026-05-1517:53 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224428 |
| 2026-04-0821:52 ET | SCHEDULE 13D | Ownership report, active investor | 0001423603-26-000008 |
| 2026-03-3116:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-134698 |
| 2026-03-1708:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-109472 |
| 2025-12-1216:30 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-317638 |
| 2025-11-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-283127 |
| 2025-11-0717:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-272538 |
| 2025-09-1212:00 ET | 8-K | 3.01 Delisting notice | 0000950170-25-114421 |
| 2025-08-1416:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108973 |
| 2025-07-1416:38 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-095608 |
| 2025-06-2517:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-090015 |
| 2025-06-1717:01 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-087485 |
| 2025-05-2818:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-077905 |
| 2025-05-2117:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-075865 |
| 2025-05-1618:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-072931 |
| 2025-05-1517:18 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072858 |
| 2025-05-1208:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-068578 |
| 2025-04-1408:03 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-053506 |
| 2025-04-0307:00 ET | 8-K | 3.01 Delisting notice | 0000950170-25-049943 |
| 2025-03-3117:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-047891 |
| 2025-03-3116:30 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950170-25-047788 |
| 2025-03-2617:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-045392 |
| 2025-03-1008:49 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-035950 |
| 2025-03-0517:00 ET | 8-K | 3.01 Delisting notice | 0000950170-25-033793 |
| 2025-02-1017:23 ET | DEF 14A | Proxy statementPeriod 2025-02-10 | 0000950170-25-017159 |
| 2025-02-1017:01 ET | DEF 14A | Proxy statementPeriod 2025-02-10 | 0000950170-25-017157 |
| 2025-01-2417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-008865 |
| 2025-01-1608:00 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-006024 |
| 2025-01-0317:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-001359 |
| 2024-12-3116:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-141623 |
| 2024-11-2016:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-129329 |
| 2024-11-1407:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-126725 |
| 2024-10-0316:30 ET | 8-K | 3.01 Delisting notice | 0000950170-24-112392 |
| 2024-08-3016:30 ET | 8-K | 3.01 Delisting notice | 0000950170-24-102375 |
| 2024-08-1416:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-097039 |
| 2024-07-2908:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-087128 |
| 2024-07-1717:19 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-084333 |
| 2024-06-1408:24 ET | DEF 14A | Proxy statementPeriod 2024-07-12 | 0000950170-24-073350 |
| 2024-05-3016:14 ET | S-1/A | Registration statement, amended | 0001193125-24-150346 |
| 2024-05-1516:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060506 |
| 2024-05-1016:17 ET | S-1 | Registration statement | 0001193125-24-136185 |
| 2024-04-2917:08 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-050040 |
| 2024-04-0417:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-041908 |
| 2024-04-0116:47 ET | 8-K | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-039431 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.